期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 143, 期 50, 页码 21127-21142出版社
AMER CHEMICAL SOC
DOI: 10.1021/jacs.1c10200
关键词
-
资金
- National Institutes of Health [R35 GM141799]
- Canadian Institutes of Health Research [FRN-148463]
- Canada Research Chair
- National Science Foundation Graduate Research Fellowship [DGE-1656518]
The increasing prevalence of multidrug-resistant bacteria has become an urgent health crisis, requiring renewed investment in the discovery and development of antibiotics. A multifaceted approach is necessary to address the antibacterial resistance crisis, with a focus on exploring validated antibacterial targets and lead molecules. Creative techniques, such as studying underexplored ecological niches or utilizing available data from genome mining efforts, can help in the search for new antibiotic leads.
The rising prevalence of multidrug-resistant bacteria is an urgent health crisis that can only be countered through renewed investment in the discovery and development of antibiotics. There is no panacea for the antibacterial resistance crisis; instead, a multifaceted approach is called for. In this Perspective we make the case that, in the face of evolving clinical needs and enabling technologies, numerous validated antibacterial targets and associated lead molecules deserve a second look. At the same time, many worthy targets lack good leads despite harboring druggable active sites. Creative and inspired techniques buoy discovery efforts; while soil screening efforts frequently lead to antibiotic rediscovery, researchers have found success searching for new antibiotic leads by studying underexplored ecological niches or by leveraging the abundance of available data from genome mining efforts. The judicious use of polypharmacology (i.e., the ability of a drug to alter the activities of multiple targets) can also provide new opportunities, as can the continued search for inhibitors of resistance enzymes with the capacity to breathe new life into old antibiotics. We conclude by highlighting available pharmacoeconomic models for antibacterial discovery and development while making the case for new ones.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据